Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Erhan Ararat

Concepts (111)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
11
2015
1183
1.100
Why?
Organoids
2
2022
36
0.980
Why?
Anti-Asthmatic Agents
1
2023
29
0.870
Why?
Asthma
2
2024
282
0.860
Why?
Metformin
1
2023
63
0.820
Why?
Lung
3
2022
501
0.730
Why?
Aspirin
2
2011
111
0.660
Why?
Cystic Fibrosis
1
2021
151
0.640
Why?
Diabetes Mellitus
1
2021
279
0.590
Why?
Neoadjuvant Therapy
3
2013
118
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2011
994
0.360
Why?
Diphosphonates
1
2010
90
0.340
Why?
Imidazoles
1
2010
128
0.340
Why?
Neoplasm Metastasis
1
2010
235
0.330
Why?
Protein Phosphatase 1
1
2009
7
0.330
Why?
Adolescent
5
2024
6414
0.330
Why?
Losartan
1
2009
27
0.330
Why?
Mitogen-Activated Protein Kinase 3
1
2009
48
0.330
Why?
Mitogen-Activated Protein Kinase 1
1
2009
49
0.330
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2010
122
0.320
Why?
Angiotensin II Type 1 Receptor Blockers
1
2009
43
0.320
Why?
Isoenzymes
1
2009
168
0.310
Why?
MAP Kinase Signaling System
1
2009
118
0.310
Why?
Genetic Predisposition to Disease
1
2011
507
0.300
Why?
Child
4
2024
6844
0.300
Why?
Humans
20
2024
49898
0.260
Why?
Antineoplastic Agents
2
2011
1175
0.250
Why?
Female
15
2024
26560
0.210
Why?
Adrenal Cortex Hormones
1
2023
99
0.210
Why?
Preoperative Care
1
2024
167
0.210
Why?
Home Care Services
1
2023
72
0.210
Why?
Spinocerebellar Ataxias
1
2022
4
0.200
Why?
Medicaid
1
2024
255
0.200
Why?
Young Adult
4
2023
4029
0.190
Why?
Body Height
1
2021
65
0.190
Why?
Mass Screening
1
2024
346
0.180
Why?
Respiration, Artificial
1
2023
292
0.180
Why?
Anthracyclines
2
2011
29
0.180
Why?
Nutritional Status
1
2021
136
0.180
Why?
Disease Progression
1
2023
820
0.180
Why?
Incidence
2
2011
986
0.150
Why?
Child, Preschool
2
2024
3875
0.140
Why?
Retrospective Studies
4
2024
6123
0.130
Why?
Adult
5
2023
13346
0.130
Why?
Multiple Myeloma
1
2010
2915
0.130
Why?
Muscular Dystrophy, Duchenne
1
2015
23
0.120
Why?
Cardiomyopathies
1
2015
114
0.110
Why?
Receptors, Progesterone
2
2013
63
0.110
Why?
Receptor, erbB-2
2
2013
74
0.110
Why?
Receptors, Estrogen
2
2013
130
0.110
Why?
Axilla
1
2013
90
0.110
Why?
Male
5
2024
25437
0.110
Why?
Prognosis
3
2015
1956
0.100
Why?
Heart
1
2015
334
0.100
Why?
Phenotype
1
2015
728
0.100
Why?
Lymphatic Metastasis
1
2013
226
0.100
Why?
Survival Rate
2
2013
905
0.100
Why?
Dacarbazine
1
2011
8
0.100
Why?
Opportunistic Infections
1
2011
59
0.090
Why?
Lymph Nodes
1
2013
257
0.090
Why?
Deoxycytidine
1
2011
28
0.090
Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.090
Why?
Fluorouracil
1
2011
55
0.090
Why?
Genes, BRCA1
1
2011
19
0.090
Why?
Phthalazines
1
2011
20
0.090
Why?
Drugs, Generic
1
2010
6
0.090
Why?
Neoplasm Recurrence, Local
2
2013
626
0.090
Why?
Taxoids
1
2010
37
0.090
Why?
Tamoxifen
1
2010
59
0.090
Why?
Antineoplastic Agents, Hormonal
1
2010
49
0.090
Why?
Piperazines
1
2011
118
0.090
Why?
Captopril
1
2009
13
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2009
74
0.080
Why?
p38 Mitogen-Activated Protein Kinases
1
2009
96
0.080
Why?
Chemotherapy, Adjuvant
3
2015
121
0.080
Why?
Enzyme Activation
1
2009
272
0.080
Why?
Muscle, Smooth, Vascular
1
2009
131
0.080
Why?
Aorta
1
2009
162
0.080
Why?
Ventricular Function, Left
1
2009
158
0.070
Why?
Age Factors
1
2011
1092
0.070
Why?
Follow-Up Studies
1
2011
2175
0.060
Why?
Myocardial Infarction
1
2009
391
0.060
Why?
Rats, Sprague-Dawley
1
2009
1578
0.060
Why?
Apoptosis
1
2010
1092
0.060
Why?
Mutation
1
2011
1292
0.060
Why?
Allergy and Immunology
1
2024
19
0.060
Why?
Treatment Outcome
2
2013
5176
0.060
Why?
Heart Failure
1
2009
505
0.050
Why?
Respiration
1
2023
99
0.050
Why?
Tracheostomy
1
2023
71
0.050
Why?
Rats
1
2009
3273
0.050
Why?
Animals
2
2022
13100
0.050
Why?
Stem Cells
1
2022
171
0.050
Why?
Emergency Service, Hospital
1
2024
487
0.040
Why?
Epithelial Cells
1
2022
209
0.040
Why?
Hospitalization
1
2024
663
0.040
Why?
Cell Differentiation
1
2022
649
0.040
Why?
Arkansas
1
2024
1987
0.040
Why?
Infant
1
2024
3572
0.030
Why?
Respiratory Function Tests
1
2015
88
0.030
Why?
Aged
3
2013
9447
0.030
Why?
United States
1
2024
4878
0.030
Why?
Neoplasm Invasiveness
1
2013
268
0.030
Why?
Disease-Free Survival
1
2013
450
0.030
Why?
Mice
1
2022
5658
0.020
Why?
Chemistry, Pharmaceutical
1
2010
33
0.020
Why?
Arthralgia
1
2010
43
0.020
Why?
Drug Administration Schedule
1
2010
369
0.020
Why?
Middle Aged
2
2013
12285
0.020
Why?
Risk Factors
1
2015
3604
0.020
Why?
Aged, 80 and over
1
2013
3136
0.020
Why?
Ararat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description